Impact BioMedical Inc.
IBO
$0.6373
$0.02534.13%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.00K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.00K | -- | -- | -- | -- |
| Cost of Revenue | 11.00K | -- | -- | -- | -- |
| Gross Profit | -4.00K | -- | -- | -- | -- |
| SG&A Expenses | 676.00K | 509.00K | 591.00K | 719.00K | 214.00K |
| Depreciation & Amortization | 288.00K | 283.00K | 279.00K | 281.00K | 279.00K |
| Other Operating Expenses | 110.00K | 115.00K | 113.00K | 45.00K | 12.00K |
| Total Operating Expenses | 1.16M | 1.01M | 875.00K | 1.13M | 626.00K |
| Operating Income | -1.15M | -1.01M | -875.00K | -1.13M | -626.00K |
| Income Before Tax | -14.35M | -1.28M | -27.10M | 4.24M | -884.00K |
| Income Tax Expenses | -- | -- | 33.00K | -- | -- |
| Earnings from Continuing Operations | -14.35M | -1.28M | -27.13M | 4.24M | -884.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 6.00K | 11.00K | 25.00K | 6.00K | -5.00K |
| Net Income | -14.35M | -1.27M | -27.11M | 4.25M | -889.00K |
| EBIT | -1.15M | -1.01M | -875.00K | -1.13M | -626.00K |
| EBITDA | -1.15M | -1.01M | -873.00K | -1.13M | -625.00K |
| EPS Basic | -1.18 | -0.11 | -2.36 | 0.37 | -0.09 |
| Normalized Basic EPS | -0.74 | -0.07 | -0.09 | 0.23 | -0.06 |
| EPS Diluted | -1.18 | -0.11 | -2.36 | 0.06 | -0.09 |
| Normalized Diluted EPS | -0.74 | -0.07 | -0.09 | 0.04 | -0.06 |
| Average Basic Shares Outstanding | 12.19M | 12.06M | 11.51M | 11.50M | 10.00M |
| Average Diluted Shares Outstanding | 12.19M | 12.06M | 11.51M | 72.00M | 10.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |